Chat with us, powered by LiveChat

Sleeping Aids Market

Sleeping Aids Market Segments: By Product Type (Mattresses and Pillows, Sleep Laboratory Services, Medication, Sleep Apnea Devices); By Sleep Disorder (Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking); and Region - Analysis of Market Size, Share & Trends for 2014 - 2019 and Forecasts to 2030

Published on: Feb-2021
Report Code: FG RTL 00522
No. of Pages: 170-350
Report Format: PDF

[ 170 + Pages Research Report ] Sleeping Aids Market to surpass USD 135.4 Billion by 2030 from USD 60.7 Billion in 2018 at a CAGR of 6.90% throughout the forecast period, i.e. 2019-30.

Product Overview

Pills and medical equipment used in the diagnosis and treatment of sleep disorders are sleep aids. Different items such as drugs, sleep labs, sleep apnea machines, and mattresses & pillows consist of sleep aids. In general, medicines include drugs that help promote sleep by restricting central nervous system behaviors. Sleep is a biological necessity that maintains metabolic homeostasis and affects and controls immune function, memory, and other cognitive functions. Drugs and medical equipment used to diagnose and treat different sleep disorders, such as sleep apnea and insomnia, are sleep aids. Lack of quality sleep results in sleep disturbances induced by medical conditions, physical disorders, environmental concerns, and psychological disorders. It is predicted that these sleep disturbances will adversely affect human health and lead to a variety of chronic illnesses, including high blood pressure, diabetes, arthritis, and stroke. It is necessary, therefore, to treat and d. Thus, it is important to treat and diagnose these disorders at an early stage.

Market Highlights

The global Sleeping Aids Market is expected to project a notable CAGR in 2030.

Global Sleeping Aids Market to surpass USD 135.4 Billion by 2030 from USD 60.7 Billion in 2018 at a CAGR of 6.90% throughout the forecast period, i.e. 2019-30. Increased consumer disposable income, combined with growing public perception of the adverse effects of sleep disorders, would increase the market size of sleep aids over the projected period. Besides, sleep disorders, such as cardiovascular diseases and diabetes, may adversely affect human health and cause chronic diseases. The above factors would provide lucrative growth for the demand for sleep aids in the coming years. The growing occurrence of sleep disorders such as chronic insomnia, obstructive sleep apnea, and narcolepsy will also stimulate business growth in the coming years with global sleep aids.

Global Sleeping Aids Market: Segments

Mattresses and Pillows Segment to grow with the highest CAGR  during 2019-30

Global Sleeping Aids Market is segmented by product type into Mattresses and Pillows, Sleep Laboratory Services, Medication, Sleep Apnea Devices. Increased consumer disposable income, combined with growing public perception of the adverse effects of sleep disorders, would increase the market size of sleep aids over the projected period. Besides, sleep disorders, such as cardiovascular diseases and diabetes, may adversely affect human health and cause chronic diseases. The above factors would provide lucrative growth for the demand for sleep aids in the coming years. The growing occurrence of sleep disorders such as chronic insomnia, obstructive sleep apnea, and narcolepsy will also stimulate business growth in the coming years with global sleep aids.

Sleep apnea to grow with the highest CAGR during 2019-30

Global Sleeping Aids Market is segmented by sleeping disorder into Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking. Sleep apnea is expected to hold a major market share of XX% in 2018 mainly on account of the widespread burden of OSA, widespread burden, the growing geriatric population, and the production of technologically advanced portable devices for sleep apnea. The majority of OSA cases remain undiagnosed, as per an article published in the News Medical Lifesciences portal in July 2020, because symptoms are often mild and there is a shortage of diagnostic tools. Therefore, to solve the problem, Finnish computer science students developed an Android program, Apnea Tracker, which uses the sensors of a smartphone or smartwatch to control the user's snoring through a microphone.

Global Sleeping Aids Market: Market Dynamics

Drivers

Growing Prevalence of Insomnia

Growing incidence of sleep disorders such as chronic insomnia, obstructive sleep apnea, and narcolepsy would stimulate global sleep development. Sleeping aids are involved in insomnia and OSA treatment, which in turn is driving the growth of the global market for sleeping aids. Besides, lifestyle changes and stressful working environments interfere with sleep patterns, leading to different sleep disorders. This acts as a key driving force that in the coming years will stimulate global sleep aids business growth.

Growing Adoption of Wearable Monitors and Sensors

Another main factor for the global sleeping aids market is the increasing adoption of wearable tracking devices and sensors. These instruments record and distribute data concerning different physiological circumstances. Sensor-equipped systems perform different purposes, such as tracking sleep disorders and assessing the quality of sleep. Besides, the quality of sleep is also hindered by long working hours, working in various shifts, hectic working climates, and stressful conditions, along with excess workload. All of these factors contribute to a growing acceptance of OTC sleeping pills that help a person fall asleep, which in turn has a positive effect on the demand for sleeping aids.

Restraint

High cost of Sleeping Aids products

Another main factor for the global sleeping aids market is the increasing adoption of wearable tracking devices and sensors. These instruments record and distribute data concerning different physiological circumstances. Sensor-equipped systems perform different purposes, such as tracking sleep disorders and assessing the quality of sleep. Besides, the quality of sleep is also hindered by long working hours, working in various shifts, hectic working climates, and stressful conditions, along with excess workload. All of these factors contribute to a growing acceptance of OTC sleeping pills that help a person fall asleep, which in turn has a positive effect on the demand for sleeping aids.

Global Sleeping Aids Market: Regions

Global Sleeping Aids Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, APAC, and MENA.

Global Sleeping Aids Market in North America held the largest market share of XX.X% in the year 2018 due to increased prevalence of sleep disorders, increased spending on health services, enhanced facilities for healthcare, and efforts and funding from public and private organizations to raise awareness of sleep hygiene and disorders. Due to the high consumption rate of sleeping pills, low production costs of related goods increased geriatric population, and widespread sleeping disorder burden, APAC is projected to be the fastest-growing area in the sleeping aids industry.

Competitive Landscape:

The global Sleeping Aids market, which is highly competitive, consists of several major players. Companies, such as BRAEBON Medical Corporation, Löwenstein Medical GmbH & Co. KG, hold a substantial market share in the Global Sleeping Aids market. Other players analyzed in this report are GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Natus Medical Incorporated, Pfizer Inc., Merck & Co. Inc., Koninklijke Philips N.V., and ResMed Inc among others

Recently, various developments have been taking place in the market. For instance, In January 2020, SleepScore Labs, which offers data-backed sleep solutions, announced its partnership with Serta Simmons Bedding LLC (SSB). These two companies partnered on a first–of–its–kind sleep study to explore the effects of sleeping on the iComfort by Serta CF4000 mattress and its ability to create comfortable and restful sleep.

Global Sleeping Aids Market is further segmented by region into:

  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – the United States and Canada

  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe
  • APAC Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and the Rest of APAC
  • MENA Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa, and Rest of MENA

Global Sleeping Aids Market: Key Players

  • Koninklijke Philips N.V

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Acelity L.P. Inc. (Kinetic Concepts, Inc.)
  • Sanofi
  • Merck & Co. Inc.
  • Pfizer Inc.
  • SleepMed Inc.
  • Cadwell Industries Inc.
  • Natus Medical Incorporated
  • Drive DeVilbiss Healthcare
  • Takeda Pharmaceutical Company Limited
  • Compumedics Limited
  • Tempur Sealy International Inc.
  • GlaxoSmithKline plc
  • Serta Simmons Bedding LLC

The global Sleeping Aids Market report also contains an analysis on:

Global Sleeping Aids Market Segments:

  • By Product Type:

    • Mattresses and Pillows
    • Sleep Laboratory Services
    • Medication
    • Sleep Apnea Devices
  • By Sleep Disorder:
    • Insomnia
    • Sleep Apnea
    • Restless Legs Syndrome
    • Narcolepsy
    • Sleep Walking
  • Global Sleeping Aids Market Dynamics
  • Global Sleeping Aids Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies Involved in the Market
  • Value Chain of the Market
  • Market Drivers and Restraints

Select License Type

$3199

Report accessible by 1 user only

In case you require a hard copy, there will be an additional charge of $500. Please email us at info@fatposglobal.com with your request

Call us

Research Assistance

US : +1 (716) 218-3733
UK : +44 (208) 1235555



Select License Type

$3199

Report accessible by 1 user only

Sample Request

Client Testimonials

FATPOS CLIENT Appriciation DURING THE PROJECT

Clients